Literature DB >> 19764098

Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer.

Cyrus Chargari1, Francois Campana, Philippe Beuzeboc, Sofia Zefkili, Youlia M Kirova.   

Abstract

Radiotherapy for locally advanced pancreatic cancer is technically difficult and frequently associated with high-grade digestive toxicity. Helical tomotherapy (HT) is a new irradiation modality that combines megavoltage computed tomography imaging for patient positioning with intensity-modulated fan-beam radiotherapy. Its recent availability opens new fields of exploration for pancreatic radiotherapy as a result of its ability to tailor very well-defined dose distributions around the target volumes. Here, we report the use of HT in two patients with locally advanced pancreatic cancer. Doses to the bowel, kidneys and liver were reduced significantly, which allowed for excellent treatment tolerance without any high-grade adverse effects in either patient.

Entities:  

Mesh:

Year:  2009        PMID: 19764098      PMCID: PMC2747067          DOI: 10.3748/wjg.15.4444

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  5 in total

1.  Potential of helical tomotherapy for sparing critical organs in a patient with AIDS who was treated for Hodgkin lymphoma.

Authors:  Cyrus Chargari; Sofia Zefkili; Youlia M Kirova
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

2.  Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.

Authors:  T R Mackie; T Holmes; S Swerdloff; P Reckwerdt; J O Deasy; J Yang; B Paliwal; T Kinsella
Journal:  Med Phys       Date:  1993 Nov-Dec       Impact factor: 4.071

3.  Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

Authors:  C Louvet; R Labianca; P Hammel; G Lledo; M G Zampino; T André; A Zaniboni; M Ducreux; E Aitini; J Taïeb; R Faroux; C Lepere; A de Gramont
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

4.  Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

Authors:  Edgar Ben-Josef; Anthony F Shields; Ulka Vaishampayan; Vainutis Vaitkevicius; Basil F El-Rayes; Patrick McDermott; Jay Burmeister; Todd Bossenberger; Philip A Philip
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

Review 5.  Pancreatic cancer.

Authors:  Donghui Li; Keping Xie; Robert Wolff; James L Abbruzzese
Journal:  Lancet       Date:  2004-03-27       Impact factor: 79.321

  5 in total
  5 in total

1.  Could helical tomotherapy do whole brain radiotherapy and radiosurgery?

Authors:  Youlia M Kirova; Cyrus Chargari; Sofia Zefkili; François Campana
Journal:  World J Radiol       Date:  2010-04-28

2.  Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapy.

Authors:  Youlia M Kirova; Vincent Servois; Cyrus Chargari; Malika Amessis; Marc Zerbib; Philippe Beuzeboc
Journal:  Invest New Drugs       Date:  2010-12-14       Impact factor: 3.850

3.  Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer.

Authors:  Jeong-Seon Ji; Chi-Wha Han; Jeong-Won Jang; Bo-In Lee; Byung-Wook Kim; Hwang Choi; Ji-Yoon Kim; Young-Nam Kang; Chul-Seung Kay; Ihl-Bohng Choi
Journal:  Radiat Oncol       Date:  2010-06-28       Impact factor: 3.481

4.  Detection and quantification of methylation in DNA using solid-state nanopores.

Authors:  Jiwook Shim; Gwendolyn I Humphreys; Bala Murali Venkatesan; Jan Marie Munz; Xueqing Zou; Chaitanya Sathe; Klaus Schulten; Farhad Kosari; Ann M Nardulli; George Vasmatzis; Rashid Bashir
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

5.  Early experience of helical tomotherapy for hepatobiliary radiotherapy.

Authors:  Carole Massabeau; Virginie Marchand; Sofia Zefkili; Vincent Servois; François Campana; Philippe Giraud
Journal:  Case Reports Hepatol       Date:  2011-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.